At close: December 13 at 4:00:01 PM EST
After hours: 7:58:38 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,080.0000
-62,054.0000
-60,079.0000
-47,941.0000
-14,709.0000
Investing Cash Flow
-6,094.0000
3,077.0000
-16,967.0000
-1,816.0000
-307.0000
Financing Cash Flow
34,702.0000
20,881.0000
59,475.0000
120,676.0000
31,611.0000
End Cash Position
39,005.0000
39,462.0000
77,563.0000
95,109.0000
24,190.0000
Capital Expenditure
-6,094.0000
-10,476.0000
-4,457.0000
-939.0000
-307.0000
Issuance of Capital Stock
--
20,804.0000
59,567.0000
129,211.0000
37,822.0000
Issuance of Debt
--
500.0000
500.0000
--
921.0000
Repayment of Debt
--
--
--
-10.0000
-5,649.0000
Free Cash Flow
-49,174.0000
-72,530.0000
-64,536.0000
-48,880.0000
-15,016.0000
12/31/2020 - 12/3/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VXRT Vaxart, Inc.
0.5920
-0.75%
TNXP Tonix Pharmaceuticals Holding Corp.
0.2405
+5.07%
JAGX Jaguar Health, Inc.
0.9693
-0.59%
INO Inovio Pharmaceuticals, Inc.
2.3200
-38.30%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
SAVA Cassava Sciences, Inc.
2.7500
-1.43%
BIOR Biora Therapeutics, Inc.
0.5597
0.00%
NVAX Novavax, Inc.
9.11
+1.00%
IBIO iBio, Inc.
2.3100
-7.97%
ATOS Atossa Therapeutics, Inc.
1.1200
-2.61%